Gluten Intolerance Treatment Market Size

  • Report ID: 5081
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Gluten Intolerance Treatment Market size was over USD 842.52 million in 2024 and is projected to reach USD 4.52 billion by 2037, witnessing around 13.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of gluten intolerance treatment is assessed at USD 1.03 billion.

The market growth is backed by the growing research on how to reverse gluten intolerance. This is resulting in the rise in clinical trials and the development of workable gluten intolerance treatments.

The rising incidence of gluten-related disorders (GRDs) and the rise in their global prevalence is predicted in about 5% of the population. The ingestion of the gluten proteins present in wheat, barley, and rye is considered the main cause of GRDs. GRDs refer to a group of conditions that are heterogeneous, reflecting their autoimmune, allergic, and non-autoimmune-allergic etiology. The increasing adoption of gluten intolerance treatment by people suffering from GRDs is will positively impact the growth of the market.


Gluten Intolerance Treatment Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gluten intolerance treatment is assessed at USD 1.03 billion.

The gluten intolerance treatment market size was over USD 842.52 million in 2024 and is projected to reach USD 4.52 billion by 2037, witnessing around 13.8% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of autoimmune, allergic, and non-autoimmune-allergic GRDs and the rising damage of gut flora will boost the market growth.

Europe industry is predicted to dominate majority revenue share of 34% by 2037, due to increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance.

The major players in the market are Takeda Pharmaceutical Company Limited, ActoBio Therapeutics, Inc., Precigen, Inc., Calypso Biotech BV, ImmunogenX, Inc., Alvine Pharmaceuticals, Dr. Falk Pharma GmbH, ImmusanT, Inc., Zedira GmbH, FunZyme BioTechnologies S.A., Amyra Biotech AG
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos